5 Results for "

RNA MTase

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "RNA MTase" in MCE Product Catalog:

Cat. No.: HY-175228
Target:  

RNA MTase Bacterial

Research Areas:  

Infection

RNA MTase-IN-1 (Compound 47) is a RNA methyltransferase (RNA MTase) inhibitor with an IC50 of 68  μM for 16S rRNA (m 1A1408) methyltransferase (NpmA). RNA MTase-IN-1 has a significant inhibitory activity against pathogen-associated aminoglycoside-resistance. RNA MTase-IN-1 can be used for resistant bacterial infections research .
loading...
    loading...
Cat. No.: HY-149362
Target:  

SARS-CoV

Research Areas:  

Infection

MTase-IN-1 (compound 26) is a potent and selective inhibitor of coronavirus nsp14 N7-methyltransferases, with an IC50 of 0.72 nM. MTase-IN-1 impairs viral RNA translation and immune evasion .
loading...
    loading...
Cat. No.: HY-150680
CAS No.: 2816165-02-1
SARS-CoV-2 nsp14-IN-1 (Compound 3) is a prototypic bisubstrate inhibitor of SARS-CoV-2 Nsp14 MTase with an IC50 value of 0.061 μM. SARS-CoV-2 nsp14-IN-1 (Compound 3) has an excellent selectivity profile over a panel of human methyltransferases, can against apanel of 10 human MTases including histone lysine, proteinarginine, and DNA and RNA MTases .
loading...
    loading...
Cat. No.: HY-P703820
Purity:  ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: RNMT; HCMT1; RNA Guanine-7 Methyltransferase; Hcm1p; RG7MT1; HMet; N7-MTase; MRNA (Guanine-N(7)-)-Methyltransferase; MRNA Cap Guanine-N(7) Methyltransferase; MRNA (Guanine-7-)Methyltransferase; MRNA Cap Guanine-N7 Methyltransferase; KIAA0398; MRNA (Guanin
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-184264
CAS No.: 1309199-94-7
Target:  

CHIKV

Research Areas:  

Infection

CHVB-066 is an alphavirus non-structural protein nsP1 inhibitor that exhibits varying degrees of inhibitory activity against nsP1 of CHIKV and VEEV. CHVB-066 inhibits MTase and GTase activities and disrupts the capping process of viral RNA, including inhibiting CHIKV replication, reducing progeny viruses, and preventing cytopathic effects. It shows varying degrees of inhibitory activity against nsP1 of CHIKV and VEEV but lacks anti-SFV replication activity, displays cross-resistance with MADTP series compounds, and requires nsP2/nsP3 mutations to develop complete drug resistance. This inhibitor with varying inhibitory activity against nsP1 of CHIKV and VEEV can be widely applied to relevant studies on chikungunya virus infection and chikungunya fever .
loading...
    loading...